Pharmacological Inhibition of BAD Ser99 Phosphorylation Enhances the Efficacy of Cisplatin in Ovarian Cancer by Inhibition of Cancer Stem Cell-like Behavior

• Main Authors: Wang, Yanxin, Chiou, Yi-Shiou, Chong, Qing-Yun, Zhang, Mengyi, Rangappa, Kanchuragoppal S, Ma, Lan, Zhu, Tao, Kumar, Alan Prem, Huang, Ruby Yun-Ju, Pandey, Vijay, Basappa, Lobie, Peter E
• 其他作者: CANCER SCIENCE INSTITUTE OF SINGAPORE
• 格式: Article
• 語言: English
• 出版: AMER CHEMICAL SOC 2023
• 主題: Science & Technology; Life Sciences & Biomedicine; Chemistry, Medicinal; Pharmacology & Pharmacy; BAD phosphorylation; NPB; ovarian cancer; cisplatin resistance; cancer stem cell; PHASE-III TRIAL; INTERGROUP TRIAL; CARBOPLATIN-PACLITAXEL; 1ST-LINE TREATMENT; SURVIVAL; PROTEIN; MECHANISMS; THERAPY; DEATH; DRUG
• 在線閱讀: https://scholarbank.nus.edu.sg/handle/10635/245936
• 機構: National University of Singapore

10.1021/acsptsci.0c00064